IPC to conduct skill development programmes on pharmacopoeial standard setting & PV for medical products from May to Dec 2019


In order to develop skill in pharmacopoeial standard setting and pharmacovigilance (PV) of medical products, the Indian Pharmacopoeia Commission (IPC) will conduct a series of workshops under skill development programme on Pharmacopoeial Standards for Pharmaceuticals (PSP) and skill development programme on Pharmacovigilance for Medical Products (PvM) from May 2019 to December 2019.

Expected outcomes of such programme is to create a workforce at national and international level to meet challenges in PV, enable and mobilize a large number of healthcare professionals to take up training and acquire requisite skills for employment, capacity building and strengthening of Qualified Person for Pharmacovigilance (QPPv) as per the requirement of the Schedule Y of D&C Act.

These skill certification programmes aim to enable and mobilize a large number of young healthcare professionals to take up training and develop skill in pharmacopoeial standard setting and pharmacovigilance of medical products, which will boost the productivity of country’s workforce by enabling them to acquire high quality skill training.  The objective of the skill development programme is to provide practical and theoretical training to pharma professionals thereby enhancing and developing their technical skills. This in turn will enhance pharmacovigilance skills of the professionals to promote patient safety. 

The programme seeks support from all stakeholders including the physicians, academicians, drug analysts, pharmacists and pharmaceutical industries. 

Skill Development Programme on Pharmacopoeial Standards for Pharmaceuticals (PSP) primarily is aimed to develop and enhance skills or technical knowledge in new pharmacopoeial standards for betterment of health of Indian and global population.

This will also broaden experience of an area of work of participants with an opportunity to learns analytical and pharmacopoeial concepts. It will create awareness about the present scenario of development of drug standards and to better understands the regulatory aspects. The target group for the programme are graduate, post graduate, research students of pharmacy, science, applied sciences, technology and engineering, QC/QA/ Regulatory personnel from pharmaceutical industry, technical persons from drug regulatory authority and academicians. 

This would help in getting employment opportunities in analytical laboratories in government and private sector, opportunities in regulatory system and CROs, able to strengthen skills on various modern sophisticated methodology in pharmacopoeia, able to understand the basic requirement of Good Pharmacopoeial Practices, able to correctly compile and interpret the analytical data and data integration, awareness in the field of drug standard development with regard to regulatory aspects in present scenario. 

The training programme is designed in a systematic way such that the classroom presentations follow hands on training on Pharmacopoeial Monograph development and harmonization. Topics included in the curriculum will cover all the facts of professional and personal challenges for the analyst. Pre assessment and post assessment of participants is done to evaluate the effectiveness of training programme.

Skill Development Programme on Pharmacovigilance for Medical Products (PvM) is meant to enhance pharmacovigilance knowledge and skills of the health care professionals, which in turn promote patient safety. The target group for this programme are young pharmacy, medical, paramedical professionals seeking care, existing professionals in pharmacovigilance, Career prospects in pharmacovigilance in government and private sector, regulatory system, CROs and public health programmes. It will enhance abilities to deliver Good Pharmacovigilance Practice at par with international requirement and also provide a platform for being an entrepreneur in PV.



Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’